CDKN2A/p16INK4a Polyclonal Antibody, Cy7 Conjugated
Product Specifications
Background
Acts as a negative regulator of the proliferation of normal cells by interacting strongly with CDK4 and CDK6. This inhibits their ability to interact with cyclins D and to phosphorylate the retinoblastoma protein.
Synonyms
Cyclin-dependent kinase inhibitor 2A; Cyclin-dependent kinase 4 inhibitor A; CDK4I; Multiple tumor suppressor 1; MTS-1; p16-INK4a; p16-INK4; p16INK4A; p12; CDKN2; MTS1.
Gene ID
1029
Swiss Prot
P42771
Cellular Locus
Nucleus
Host
Rabbit
Cross Reactivity
Human
Immunogen
31-100/156
Target
CDKN2A/p16INK4a
Clonality
Polyclonal
Isotype
IgG
Conjugation
Cy7
Source
KLH conjugated synthetic peptide derived from human CDKN2A
Applications
FCM, IF (IHC-P), IF (IHC-F), IF (ICC)
Purification
Purified by Protein A.
Excitation Emission
743nm/767nm
Concentration
1µg/µl
Dilution
FCM (1:20-100), IF (IHC-P) (1:50-200), IF (IHC-F) (1:50-200), IF (ICC) (1:50-200)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Specificity
Targets p16INK4a
Gene ID URL
1029
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
P1000-38A-PE 100 µL
P19 (CDKN2D, Cyclin-dependent kinase 4 inhibitor D, p19-INK4d) -PE
Ask
View Details 